Sadegh Saghafinia

7.1k total citations · 1 hit paper
10 papers, 1.0k citations indexed

About

Sadegh Saghafinia is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sadegh Saghafinia has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Sadegh Saghafinia's work include Pancreatic and Hepatic Oncology Research (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Epigenetics and DNA Methylation (2 papers). Sadegh Saghafinia is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Epigenetics and DNA Methylation (2 papers). Sadegh Saghafinia collaborates with scholars based in Switzerland, United States and Canada. Sadegh Saghafinia's co-authors include Douglas Hanahan, Giovanni Ciriello, Marco Mina, Iacovos P. Michael, Nicolò Riggi, Peng Zhang, Qiqun Zeng, José A. Galván, Inti Zlobec and Wei Jiao and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Sadegh Saghafinia

10 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synaptic proximity enables NMDAR signalling to promote brain metastasis

2019 352 citations Qiqun Zeng, Iacovos P. Michael et al. Nature profile →

Peers

Countries citing papers authored by Sadegh Saghafinia

Since Specialization

Citations

This map shows the geographic impact of Sadegh Saghafinia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadegh Saghafinia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadegh Saghafinia more than expected).

Fields of papers citing papers by Sadegh Saghafinia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadegh Saghafinia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadegh Saghafinia. The network helps show where Sadegh Saghafinia may publish in the future.

Co-authorship network of co-authors of Sadegh Saghafinia

This figure shows the co-authorship network connecting the top 25 collaborators of Sadegh Saghafinia. A scholar is included among the top collaborators of Sadegh Saghafinia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadegh Saghafinia. Sadegh Saghafinia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	OPN-6602, an Orally Bioavailable EP300/CBP Bromodomain Inhibitor, Targets Multiple Myeloma through Suppression of IRF4 and MYC 2024 ·Blood ·Bernice Matusow, Sadegh Saghafinia, (unknown), (unknown), Panyu Chen, Christine Nichols, Parmveer Singh, (unknown), Jackie Walling, Gideon Bollag	1
2	Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion 2022 ·Science ·Qiqun Zeng, Sadegh Saghafinia, Agnieszka Chryplewicz, Nadine Fournier, (unknown), Yuqing Xie, (unknown), (unknown), (unknown), José A. Galván, Eva Karamitopoulou, Inti Zlobec, (unknown), (unknown), Peng Zhang, (unknown), Mark A. Rubin, Mélanie Tichet, Krisztián Homicskó, Douglas Hanahan	62
3	Cancer Cells Retrace a Stepwise Differentiation Program during Malignant Progression 2021 ·Cancer Discovery ·Sadegh Saghafinia, Krisztián Homicskó, Annunziata Di Domenico, Stephan Wullschleger, Aurel Perren, Ilaria Marinoni, Giovanni Ciriello, Iacovos P. Michael, Douglas Hanahan	29
4	A miR-375/YAP axis regulates neuroendocrine differentiation and tumorigenesis in lung carcinoid cells 2021 ·Scientific Reports ·Xiaojing Yang, (unknown), (unknown), Sadegh Saghafinia, (unknown), (unknown), Xiantao Wang, Christopher J.B. Nicol, Iacovos P. Michael, Markus Hafner, Xiaolong Yang, Neil Renwick	13
5	Synaptic proximity enables NMDAR signalling to promote brain metastasis breakdown → 2019 ·Nature ·Qiqun Zeng, Iacovos P. Michael, Peng Zhang, Sadegh Saghafinia, Graham Knott, Wei Jiao, Brian D. McCabe, José A. Galván, Hugh P. C. Robinson, Inti Zlobec, Giovanni Ciriello, Douglas Hanahan	352
6	ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis 2019 ·Developmental Cell ·Iacovos P. Michael, Sadegh Saghafinia, Mélanie Tichet, Nadine Zangger, Ilaria Marinoni, Aurel Perren, Douglas Hanahan	30
7	A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis 2019 ·Proceedings of the National Academy of Sciences ·Iacovos P. Michael, Sadegh Saghafinia, Douglas Hanahan	40
8	Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors 2018 ·Cell Reports ·Sadegh Saghafinia, Marco Mina, Nicolò Riggi, Douglas Hanahan, Giovanni Ciriello	230
9	Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies 2017 ·Cancer Cell ·Marco Mina, Franck Raynaud, Daniele Tavernari, Elena Battistello, Stéphanie Sungalee, Sadegh Saghafinia, (unknown), Francisco Sánchez-Vega, Nikolaus Schultz, Elisa Oricchio, Giovanni Ciriello	81
10	Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling 2016 ·Cell Reports ·Elizabeth Allen, Pascal Miéville, Carmen M. Warren, Sadegh Saghafinia, Leanne Li, (unknown), Douglas Hanahan	179

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact